Schrodinger (NASDAQ:SDGR) Trading Down 5.9% - What's Next? - MarketBeat
4 hours ago • Google News
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications.
4 hours ago • Google News
4 weeks ago • Google News